[Histopathological changes of the Fallopian tubes during treatment with norethisterone enanthate].
Bur Ge Gonzalez Pena
Lucheta Y Luis Antelo
M
M
D001695:Biology; D002477:Cells; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D005187:Fallopian Tubes; D005193:Family Planning Services; D005835:Genitalia; D005836:Genitalia, Female; D006653:Histology; D007267:Injections; D009640:Norethindrone; D010827:Physiology; D012106:Research; D014566:Urogenital System
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D009640:Norethindrone
Biology; Clinical Research; Contraception; Contraceptive Agents, Female--administraction and dosage; Contraceptive Agents, Female--side effects; Contraceptive Agents, Progestin--administraction and dosage; Contraceptive Agents, Progestin--side effects; Contraceptive Agents--administraction and dosage; Contraceptive Agents--side effects; Cytologic Effects; Fallopian Tubes; Family Planning; Genitalia; Genitalia, Female; Histology; Injectables; Norethindrone Enanthate--administraction and dosage; Norethindrone Enanthate--side effects; Norethindrone--administraction and dosage; Norethindrone--side effects; Physiology; Research Methodology; Urogenital System